Author

M. E. Ragu

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Research Focus:gene regulatory network inference· 2 Organism:human· 2 Approach:statistical model· 2 Assay:whole-exome sequencing· 2 Research Focus:clustering· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

C.-H. Yip· 2 shared J.-W. Pan· 2 shared P. Rajadurai· 2 shared S.-H. Teo· 2 shared C. Caldas· 1 shared J. Lim· 1 shared J. M. C. Lim· 1 shared L.-M. Looi· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 40 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

C.-H. Yip

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Clustering of HR+/HER2- breast cancer in an Asian cohort is driven by immune phenotypes

J.-W. Pan, M. E. Ragu, W.-Q. Chan, S. N. Hasan, T. Islan, L.-Y. Teoh, S. Jamaris, M.-H. See, C.-H. Yip, P. Rajadurai, L.-M. Looi, N. A. Mohd Taib, O. M. Rueda, C. Caldas, S.-F. Chin, , S.-H. Teo

This study identifies immune phenotype-driven clustering in HR+/HER2- breast cancer from an Asian cohort, deviating from the luminal A-luminal B classification seen in European populations.

bioRxiv · Dec 7, 2023Cancer Biology

TP53 somatic mutations in Asian breast cancer are associated with subtype-specific effects

M. E. Ragu, J. M. C. Lim, P.-S. Ng, C.-H. Yip, P. Rajadurai, S.-H. Teo, J.-W. Pan

The paper analyzes TP53 mutations in Asian breast cancer samples and finds subtype-specific effects on HR deficiency and transcriptional changes.

bioRxiv · Mar 31, 2022 · PreprintCancer Biology